How autophagy affects senescent-cell clearance

Senescent cells can accumulate in old tissues when the immune system fails to remove them. A 5 October 2026 Nature Aging paper examined how that failure relates to chaperone-mediated autophagy (CMA), a selective protein-recycling pathway.

CMA delivers selected soluble proteins directly to lysosomes for degradation. Macroautophagy uses a different route, enclosing material in vesicles before delivery to lysosomes. The distinction matters for both the mechanism and any drug intended to change it.

CMA loss in senescent cells and macrophages

In cultured cells, loss of CMA altered the proteins and signals released during senescence. These secretions promoted senescence in neighbouring cells and suppressed CMA in macrophages, impairing the macrophages’ ability to engulf senescent cells.

The researchers then deleted the CMA-related receptor LAMP2A in mouse macrophages. The mice accumulated more senescent-cell markers in several tissues and cleared senescent cells more slowly during wound healing.

The cell experiments and macrophage-specific knockout support a causal role for CMA in this clearance pathway. They do not establish that manipulating it extends lifespan.

Activating CMA in mice

An experimental small-molecule CMA activator reduced senescence-associated markers in aged mice after prolonged dosing. It also improved several disease measures in a bleomycin-induced mouse model of lung fibrosis.

Senescence markers are imperfect proxies for the number of senescent cells. The researchers did not measure a lifespan extension, and these findings have no direct human clinical outcome.

This CMA activator was separate from Retro Biosciences’ RTR242 programme, which proposes to restore lysosomal acidity.

Longer studies will need to test sustained tissue function and survival, as well as possible effects on the short-lived senescence that helps repair injured tissue.